ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $91,000 | +35.8% | 4,400 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $67,000 | -33.0% | 4,400 | -0.7% | 0.00% | 0.0% |
Q1 2018 | $100,000 | -24.8% | 4,431 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $133,000 | +3.9% | 4,431 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $128,000 | -8.6% | 4,431 | +0.7% | 0.00% | 0.0% |
Q3 2016 | $140,000 | -2.1% | 4,400 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $143,000 | +16.3% | 4,400 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $123,000 | -21.7% | 4,400 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $157,000 | +7.5% | 4,400 | 0.0% | 0.00% | +100.0% |
Q3 2015 | $146,000 | -20.7% | 4,400 | 0.0% | 0.00% | -50.0% |
Q2 2015 | $184,000 | +28.7% | 4,400 | 0.0% | 0.00% | +100.0% |
Q1 2015 | $143,000 | +2.1% | 4,400 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $140,000 | +28.4% | 4,400 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $109,000 | +10.1% | 4,400 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $99,000 | -7.5% | 4,400 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $107,000 | -31.8% | 4,400 | -30.2% | 0.00% | 0.0% |
Q4 2013 | $157,000 | – | 6,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
First Washington CORP | 176,950 | $3,976,000 | 2.06% |
SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |